KRMD (KORU Medical Systems) Market Value to Book Value Ratio

KORU Medical Systems (KRMD) concentrates its production of home drug delivery systems in the US, leveraging the expansion of the chronic care segment. This daily price chart for KRMD confirms the success of the "razor and blade" strategy, where pump sales generate constant demand for high-margin consumables, ensuring a stable FCF at 8.10. Excess liquidity and a steady cash flow allow the company to fully cover its capital expenditures.

The patent-protected drug delivery ecosystem of KORU Medical Systems (KRMD) creates significant brand value, which investors price in via a premium over the net asset value. By analyzing the historical P/BV multiple of KORU Medical Systems (KRMD), one can determine the gap between the market price and the book value of capital, reflecting the market's confidence in the business's long-term sustainability and its ability to generate excess profit.